APDN241220P2500
- 0.00
- 0.000.00%
Applied DNA Sciences Newsroom
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced From Linea DNA
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday
10-K: FY2024 Annual Report
Applied DNA Sciences Announces Leadership Changes and Restructuring
Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments.
Express News | Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments
8-K: Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
Express News | Applied DNA Reveals Immediate Promotion Of COO Judith Murrah To President; James Hayward Remains Chairman Of Board And CEO
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot
Express News | Applied DNA Sciences Inc - Targeting of Operating Expense Reductions of 15% Compared to Fiscal 2024
Express News | Applied DNA Sciences Inc - Net Loss for Q4 of Fiscal 2024 Was $0.32 per Share
Express News | Applied DNA Sciences Inc - Pursuing Divestiture of Certaint Platform, Implements Changes to Corporate Leadership
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q4 Revenue $813,106, Vs. Street Est of $0.9M
Earnings Scheduled For December 17, 2024
Earnings Preview: APDN to Report Financial Results Post-market on December 17
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide With Update on GMP Manufacturing Facility Build-out
WHO Extends Mpox Emergency; Canada Reports First Clade I Case
Express News | World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
APDN Files for Resale of 41.6 Million Shares by Selling Stockholders